4.5 Article

Giant osteoclasts after long-term bisphosphonate therapy: diagnostic challenges

期刊

NATURE REVIEWS RHEUMATOLOGY
卷 5, 期 6, 页码 341-346

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nrrheum.2009.87

关键词

-

资金

  1. NIA NIH HHS [P01 AG013918-029002, P01 AG013918, P01 AG013918-110008] Funding Source: Medline
  2. BLRD VA [I01 BX000436] Funding Source: Medline
  3. VA [873765, 5I01BX000436-07] Funding Source: Federal RePORTER

向作者/读者索取更多资源

Background. a 55-year-old woman with a 5-year history of osteoporosis treated for 4 years with an oral aminobisphosphonate presented with a recent vertebral fracture. a bone biopsy specimen revealed giant osteoclasts with more than 40 nuclear profiles. Investigations. Bone mineral density determinations, measurement of serum 25-hydroxyvitamin D, intact parathyroid hormone, calcium, inorganic phosphorus, alkaline phosphatase and creatinine levels, urinary excretion levels of the N-telopeptide of type 1 collagen, and bone biopsy. examination of the patient and review of the bone specimen. Diagnosis. Giant osteoclasts after long-term bisphosphonate use, without evidence of malignancy. Management. Interpretation of the bone biopsy specimen listed several bone disorders. the bone specimen was reviewed and the histological differential diagnosis was carefully considered. the giant osteoclasts were detached from bone and frequently apoptotic in a normal marrow stroma, with low-to-normal amounts of osteoid and osteoblasts. these features are typical of giant osteoclast formation after long term aminobisphosphonate therapy. the patient was reassured that the bone findings were unlikely to be detrimental. aminobisphosphonate treatment was reinstituted, and 1 year later the patient was asymptomatic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据